Alterity Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 28 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2009 | Dec2009 | Jun2010 | Dec2010 | Jun2011 | Dec2011 | Jun2012 | Dec2012 | Dec2013 | Dec2014 | Dec2015 | Dec2016 | Jun2017 | Dec2017 | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2021 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -0.00B | -0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||
| Depreciation and Depletion | 0.00B | 0.00B | ||||||||||||||||||||||||||
| Share-based Compensation | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||||||||
| Cash from Discontinued Operations | ||||||||||||||||||||||||||||
| Gains from Investment Securities | ||||||||||||||||||||||||||||
| Cash from Operations | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | 0.00B | -0.01B | ||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | ||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Receivables | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | ||||||||||||||||||||||
| Change in Account Payables | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | ||||||||||||||||||||||
| Change in Accured Expenses | -0.00B | -0.00B | ||||||||||||||||||||||||||
| Other Working Capital Changes | -0.00B | |||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | -0.00B | -0.00B | -0.00B | 0.00B | ||||||||||||||||||||||||
| Sales of Property, Plant and Equipment | ||||||||||||||||||||||||||||
| Cash from Investing Activities | -0.00B | -0.00B | -0.00B | -0.00B | ||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.00B | 0.00B | 0.00B | |||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||
| Cash from Financing Activities | -0.00B | -0.00B | 0.00B | 0.00B | ||||||||||||||||||||||||
| Exchange Rate Effect | -0.01B | -0.00B | -0.01B | 0.00B | -0.00B | 0.00B | -0.00B | |||||||||||||||||||||
| Change in Cash | -0.09B | 0.07B | -0.00B | -0.08B | 0.03B | 0.03B | 0.04B | 0.01B | ||||||||||||||||||||
| Beginning Cash Balance | 23,263.49B | 0.01B | 0.01B | 0.02B | ||||||||||||||||||||||||
| Free Cash Flow | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | 0.00B | -0.01B | ||||||||||||||||||||
| Net Cash Flow | -0.00B | -0.00B | -0.00B | -0.00B | -0.01B | -0.01B | 0.00B | -0.01B |